GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

US-China tech dynamics shine light on thriving underwater drone investments, notes GlobalData

In a race to strengthen underwater capabilities, the US and China are accelerating efforts in advanced technologies such as the Manta Ray underwater drone, highlighting their strategic significance. The recent developments highlight the critical role of underwater drones in military, environmental, and infrastructure applications. With significant investments driving innovation in endurance, navigation, and data collection […]
Read more

Diagnosed prevalent cases of chronic kidney disease to reach 22.97 million across 7MM in 2033, predicts GlobalData

The diagnosed prevalent cases of chronic kidney disease (CKD) across the seven major markets (*7MM) are projected to increase at an annual growth rate (AGR) of 0.90% from 21.08 million in 2023 to 22.97 million in 2033, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “Chronic Kidney Disease: Epidemiology Forecast to 2033,” […]
Read more

GenAI to revolutionize financial services with enhanced decision-making and personalization, says GlobalData

Generative AI (genAI) is set to transform financial services across banking, insurance, and wealth management. This technology is advancing through distinct phases, offering transformative capabilities such as enhanced decision-making, personalized services, and innovative product development. With significant funding growth and increasing adoption, genAI is set to drive unprecedented innovation and operational efficiency in the industry, […]
Read more

AI and robotics unlock sustainable efficiency in oil and gas sector, says GlobalData

Artificial intelligence (AI) and robotics are leading the transformative changes in the oil and gas sector, accelerating advancements in operational efficiency, safety, and environmental sustainability. These technologies are reshaping how the sector approaches exploration, production, refining, and logistics, instituting a new era of innovations for heightened productivity, efficiency, sustainability, and safety, according to GlobalData, a […]
Read more

Ajovy benefits diminish with migraine treatment cessation and re-initiation, says GlobalData

The interim results from the observational, prospective Phase IV Pan-European Real-Life (PEARL) study, presented at the 10th Congress of the European Academy of Neurology, indicate that treatment cessation and re-initiation can reduce the benefits of Teva Pharmaceutical’s Ajovy for migraine management. Continuous administration of Ajovy is crucial for effective prevention, challenging current guidelines that recommend […]
Read more

VNS and cenobamate combo therapy success paves way for cenobamate monotherapy, says GlobalData

At the recently held 10th Congress of the European Academy of Neurology (EAN), two investigator-led ePresentation sessions on epilepsy outlined the effectiveness of a combination of a new anti-seizure medication (ASM), Xcopri (cenobamate) and vagus nerve stimulation (VNS) in managing drug-resistant epilepsy (DRE). The combination therapy demonstrated significant improvements in seizure control, highlighting its potential […]
Read more

Precision medicine transforms healthcare beyond oncology, says GlobalData

Precision medicine is reshaping healthcare beyond its traditional focus on oncology. This innovative approach tailors medical treatments to individual genetic, environmental, and lifestyle factors, enhancing disease prevention, diagnosis, and treatment efficacy. From reproductive health advancements like biomarker screenings in IVF to pandemic preparedness initiatives, precision medicine is expanding its impact across diverse medical fields, promising […]
Read more

AI-augmented robotics to elevate Industry 4.0, says GlobalData

The integration of advanced robotics and artificial intelligence (AI) is transforming several industries such as manufacturing, healthcare, automotive, and aerospace and forging a path towards the realization of Industry 4.0. While companies are heavily investing in proprietary technologies for innovation and productivity, challenges like cybersecurity and high costs remain. Collaborative R&D efforts and standardized policies […]
Read more

EMA approval of Sanofi/Regeneron’s Dupixent fills biologic gap in COPD, says GlobalData

Following the European Medicines Agency (EMA) approval of Sanofi/Regeneron’s Dupixent (Dupilumab) on 03 July 2024: Asiyah Nawab, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “Dupixent, a monoclonal antibody (mAb) targeting interleukin-4 (IL4) and interleukin-13 (IL13) pathways, has been approved by the EMA as the first biologic for uncontrolled chronic […]
Read more

Companion diagnostics drive precision oncology growth and accessibility, says GlobalData

Companion diagnostic (CDx) tests play a pivotal role in modern oncology by identifying specific biomarkers that guide personalized cancer treatments. These tests, such as HER2 testing in breast cancer, determine eligibility for targeted therapies like trastuzumab. The evolving landscape of CDx tests is marked by decreasing costs, driven by technological advancements and economies of scale, […]
Read more

Medical tourism gains prominence in filing documents of companies, finds GlobalData

Medical tourism has been gaining momentum and it is also evident from companies’ discussions that it presents a big opportunity. An in-depth analysis of the filing documents reveals that companies are focusing on the needs of international patients, including access to skilled healthcare professionals, advanced treatments, and world-class facilities, reveals the Company Filing Analytics Database […]
Read more

Volkswagen’s $5 billion bet on Rivian gets influencer attention on X, reveals GlobalData

Volkswagen (VW) and US-based electric vehicle (EV) startup Rivian Automotive have emerged as trending companies among the influencers on social media platform “X,” following the German automaker’s announcement of a strategic investment of up to $5 billion in Rivian. This partnership is perceived as mutually beneficial wherein Volkswagen secures access to Rivian’s advanced software-defined vehicle […]
Read more

Humanoid robotics conversations surge 80% on social media platform X during H1 2024, reveals GlobalData

The field of humanoid robotics is evolving rapidly, merging sophisticated AI with precise mechanics to create robots that closely emulate human behaviors. Influencers on social media platform “X” are actively discussing on how these technological advancements could transform various sectors, which led to 80% rise in conversations during the first half (H1) of 2024 (January-June). […]
Read more
1 … 59 60 61 62 63 … 209